SCHEMBL7955658

SCHEMBL7955658

NC(=O)c1cc(-c2cccnc2Cl)n2c1CSC2

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
RAB9A P51151 2/20 0.34
POLB P06746 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ADRA1D P25100 1/20 0.33
DHODH Q02127 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PARP1 P09874 1/20 0.33
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957597 0.79 HPGD (0.37) SMN1; SMN2LMNAALDH1A1HPGDRAB9A
SCHEMBL7946450 0.77 RAB9A (0.36) MEN1KMT2ANPC1SMN1; SMN2LMNA
SCHEMBL8329574 0.76 PTPN11 (0.33) SMN1; SMN2LMNAALDH1A1RAB9AKDM4E
SCHEMBL7955454 0.76 CYP11B2 (0.36) NPC1ALDH1A1RAB9APOLBTDP1
Iodide SCHEMBL10859030 0.75 MKNK1 (0.46) KMT2ARXFP1
SCHEMBL10742532 0.68 CHEK1 (0.35) MEN1KMT2APOLB
SCHEMBL10857099 0.66 KDM4E (0.40) KMT2ANPC1ALDH1A1RAB9AKDM4E
SCHEMBL38770 0.65 SMN1; SMN2 (0.68) NPC1SMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL30680438 0.65 SMN1; SMN2 (0.68) NPC1SMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL7954859 0.65 MKNK1 (0.43) NPC1SMN1; SMN2ALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US disclosed
EP-0833635-A1 NOVEL USE FOR PYRROLE DERIVATIVES Aventis Pharma S.A. (FR) 1998-04-08 EP disclosed
WO-1997000073-A1 NOVEL USE FOR PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1997-01-03 WO disclosed